Robert Friel - PerkinElmer Chairman
| PKIDelisted Stock | USD 115.24 0.74 0.64% |
Chairman
Mr. Robert F. Friel is Chairman of the Board, Chief Executive Officer of PerkinElmer Inc. He is no longer President from August 2007 through December 2018. Prior to being appointed President and Chief Executive Officer in February 2008 and Chairman in April 2009, Mr. Friel had served as President and Chief Operating Officer since August 2007, and as Vice Chairman and President of our Life and Analytical Sciences unit since January 2006. Mr. Friel was our Executive Vice President and Chief Financial Officer, with responsibility for business development and information technology in addition to his oversight of the finance functions, from October 2004 until January 2006. Mr. Friel joined PerkinElmer in February 1999 as our Senior Vice President and Chief Financial Officer. Prior to joining PerkinElmer, he held several senior management positions with AlliedSignal, Inc., now Honeywell International. He received a Bachelor of Arts degree in economics from Lafayette College and a MS degree in taxation from Fairleigh Dickinson University. Mr. Friel is currently a director of NuVasive, Inc. and Xylem Inc., and previously served as a director of CareFusion Corporation until its acquisition by Becton, Dickinson and Company in March 2015. He also previously served on the national board of trustees for the March of Dimes Foundation. since 2019.
| Age | 67 |
| Tenure | 5 years |
| Phone | 781 663 6900 |
| Web | https://www.perkinelmer.com |
PerkinElmer Management Efficiency
The company has Return on Asset of 0.0369 % which means that on every $100 spent on assets, it made $0.0369 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0706 %, implying that it generated $0.0706 on every 100 dollars invested. PerkinElmer's management efficiency ratios could be used to measure how well PerkinElmer manages its routine affairs as well as how well it operates its assets and liabilities.The company has 3.92 B in debt with debt to equity (D/E) ratio of 0.65, which is OK given its current industry classification. PerkinElmer has a current ratio of 1.98, which is typical for the industry and considered as normal. Debt can assist PerkinElmer until it has trouble settling it off, either with new capital or with free cash flow. So, PerkinElmer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PerkinElmer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PerkinElmer to invest in growth at high rates of return. When we think about PerkinElmer's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | CHAIRMAN Age | ||
| William Rastetter | Illumina | 66 | |
| Adam Schechter | Laboratory of | 59 | |
| Jonathan Ayers | IDEXX Laboratories | 61 | |
| James Cullen | Agilent Technologies | 72 | |
| Jay Flatley | Illumina | 65 | |
| Mitchell Rales | Danaher | 67 | |
| Douglas Berthiaume | Waters | 66 | |
| John Climax | ICON PLC | 71 | |
| Ciaran Murray | ICON PLC | 53 | |
| Thomas Lynch | ICON PLC | 57 | |
| Flemming Ornskov | Waters | 62 | |
| David King | Laboratory of | 61 | |
| Christopher OConnell | Waters | 51 | |
| James Foster | Charles River Laboratories | 70 | |
| Thomas Lynch | Thermo Fisher Scientific | 66 | |
| Jim Manzi | Thermo Fisher Scientific | 68 | |
| Steven Rales | Danaher | 73 | |
| Ari Bousbib | IQVIA Holdings | 63 | |
| Robert Spoerry | Mettler Toledo International | 65 | |
| Boon Koh | Agilent Technologies | 70 | |
Management Performance
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 |
PerkinElmer Leadership Team
Elected by the shareholders, the PerkinElmer's board of directors comprises two types of representatives: PerkinElmer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PerkinElmer. The board's role is to monitor PerkinElmer's management team and ensure that shareholders' interests are well served. PerkinElmer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PerkinElmer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michel Vounatsos, Independent Director | ||
| Sylvie Gregoire, Independent Director | ||
| Pascale Witz, Independent Director | ||
| Miriame Victor, Chief Commercial Officer, Senior Vice President | ||
| Jonathan DiVincenzo, Sr. VP and President of Environmental Health | ||
| Patrick Sullivan, Independent Director | ||
| Stephen Willoughby, VP ESG | ||
| Tajinder Vohra, Senior Vice President Global Operations | ||
| Prahlad Singh, Senior Vice President and President - Diagnostics | ||
| Robert Friel, Chairman, CEO and President and Member of Fin. Committee | ||
| Vicki Sato, Independent Director | ||
| Maxwell Krakowiak, VP CFO | ||
| Daniel Tereau, Senior Vice President Strategy and Business Development | ||
| Alexandros Michas, Independent Non-Executive Chairman of the Board | ||
| Nicholas Lopardo, Lead Independent Director | ||
| Franklin Witney, Director | ||
| Joel Goldberg, Senior Vice President - Administration, General Counsel, Secretary | ||
| James Corbett, Sr. VP and President of Human Health | ||
| Kenton Sicchitano, Independent Director | ||
| Samuel Chapin, Independent Director | ||
| James Mock, Chief Financial Officer, Senior Vice President | ||
| Andrew Okun, Chief Accounting Officer, Vice President, Treasurer | ||
| Peter Barrett, Independent Director | ||
| Deborah Butters, Chief Human Resource Officer, Senior Vice President | ||
| Frank Witney, Independent Director | ||
| John Letcher, Senior Vice President - Human Resources | ||
| Alexis Michas, Independent Non-Executive Chairman of the Board | ||
| Jon DiVincenzo, Senior Vice President and Presidentident - Environmental Health | ||
| Masoud Toloue, VP Diagnostics | ||
| Frank Wilson, CFO and Sr. VP |
PerkinElmer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PerkinElmer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 22.3 B | |||
| Shares Outstanding | 126.41 M | |||
| Shares Owned By Insiders | 0.26 % | |||
| Shares Owned By Institutions | 86.25 % | |||
| Number Of Shares Shorted | 3.53 M | |||
| Price To Earning | 21.07 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PerkinElmer in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PerkinElmer's short interest history, or implied volatility extrapolated from PerkinElmer options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PerkinElmer using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in PerkinElmer Stock
If you are still planning to invest in PerkinElmer check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PerkinElmer's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |